New Multi-omics Database with Real-time analysis.Try now >>
Title | Total cells | ||
1 | A human fetal lung cell atlas uncovers proximal-distal gradients of differentiation and key regulators of epithelial fates Dataset 1: All cells cell type: CD16-negative, CD56-bright natural killer cell, human expressed genes: TOX2 | ||
2 | A spatially resolved atlas of the human lung characterizes a gland-associated immune niche Dataset 1: All cells and nuclei cell type: NK_CD56bright expressed genes: TOX2 | ||
3 | Blood and immune development in human fetal bone marrow and Down syndrome Dataset 1: Fetal Bone Marrow (10x) cell type: CD56 bright NK expressed genes: TOX2 | ||
4 | Cross-tissue immune cell analysis reveals tissue-specific features in humans Dataset 1: Global cell type: NK_CD56bright_CD16- expressed genes: TOX2 | ||
5 | Local and systemic responses to SARS-CoV-2 infection in children and adults Dataset 2: Airway cell type: NK cd56hi expressed genes: TOX2 | ||
6 | Ovarian cancer mutational processes drive site-specific immune evasion Dataset 1: MSK SPECTRUM - CD4+ T cells, CD8+ T cells, ILCs and NK cells cell type: NK.CD56 expressed genes: TOX2 | ||
7 | Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies Dataset 6: DCM/ACM heart cell atlas: Lymphoids cell type: NK_CD56hi expressed genes: TOX2 | ||
8 | Single-cell reconstruction of the early maternal–fetal interface in humans Dataset 1: Pregnant Uterus (All) cell type: NK CD16+ expressed genes: TOX2 | ||
9 | Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 Dataset 1: Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 cell type: NK_CD56++ expressed genes: TOX2 |